Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial update evaluating mFOLFIRINOX with or without stereotactic body radiotherapy for locally advanced, non-resectable p…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery [NA]
A clinical trial update describing a structured follow-up intervention to assess glucose status after pancreatic cancer surgery. The study i…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant/adjuvant therapy with sintilimab (PD-1 inhibitor) plus nab-paclitaxel and gemcitabine for rese…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV [Phase 1, Phase 2]
A Phase 1/2 trial evaluating liposomal irinotecan with oxaliplatin and bevacizumab versus liposomal irinotecan with 5-FU/leucovorin in advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Role of Exosomes in Pancreatic Cancer Progression
A clinical trial is investigating the role of exosomes in pancreatic cancer progression and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Bortezomib combined with a PD-1 monoclonal antibody and the MFOLFIRINOX regimen for metastatic pancreati…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating adebrelimab in combination with liposomal irinotecan, oxaliplatin, and 5-FU/leucovorin conversion therapy for local…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler
An ongoing clinical trial at University Hospital Heidelberg is evaluating pancreatic fistula rates after distal pancreatectomy using the AEO…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.
A retrospective study examined risk factors in patients undergoing pancreaticoduodenectomy and developed a nomogram to standardize PD surgic…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: TAS102 in Combination With NAL-IRI in Advanced GI Cancers [Phase 1, Phase 2]
This document provides an update on an ongoing Phase 1/2 clinical trial evaluating the combination of TAS-102 with nanoliposomal irinotecan …
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a combination of mFOLFIRINOX, Anlotinib, and Sintilimab for locally advanced or metastatic pancreatic …
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: PREVENPANC Project: a Spanish Multicenter Study for Pancreatic Cancer Prevention
This clinical trial update describes the PREVENPANC project, a Spanish multicenter study aimed at pancreatic cancer prevention, which is not…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of surufatinib and camrelizumab with AS as first-line therapy for advanced metastatic …
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions [NA]
This entry reports a clinical trial evaluating Joint-AI for diagnosing pancreatic solid lesions; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer [EARLY_Phase 1]
An early-phase trial evaluating endoscopic ultrasound-guided intratumoral CAR-NK cell therapy for advanced, non-resectable pancreatic cancer…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial assessing sequential NKG2D CAR-NK cell therapy as second-line chemotherapy for non-resectable pancreati…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
This clinical trial update describes a study comparing questionnaires versus motion trackers to assess physical activity in cancer patients …
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
This clinical trial is evaluating whether the neutrophil-to-lymphocyte ratio and CA 19-9 levels can predict perineural invasion in pancreati…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study of CEND-1 with neoadjuvant FOLFIRINOX, with or without panitumumab, in colon and pancreatic cance…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients [NA]
A Sun Yat-sen University-sponsored clinical trial is currently recruiting to evaluate whether oral immunonutrition can reduce acute toxicity…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer [Phase 2]
Clinical trial update showing AK104 in combination with chemotherapy as first-line treatment for advanced pancreatic cancer in a Phase 2 stu…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
Ongoing clinical trial evaluating Ga-68 grazytracer PET imaging to monitor responses to immunotherapy in pancreatic cancer.
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer. [Phase 1]
A Phase I trial evaluating TBI-1401 (HF10) in combination with chemotherapy for unresectable pancreatic cancer (Stage III/IV) is listed, wit…